跳至主要内容
临床试验/NCT00700505
NCT00700505已完成不适用

A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy

ThermaRx, Inc.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Post-void residual urinary volume (PVR)

研究概览

简要总结

To determine the safety and efficacy of the ThermaRx heating device for the application of controlled low level heat to improve symptoms of LUT dysfunction (hesitancy, urgency).

详细描述

This study will assess the safety and efficacy of ThermaRx heat treatment in subjects who have urinary hesitancy.

The rationale for this approach is based on anecdotal evidence and case reports suggesting that urinary hesitancy can be effectively reduced by external skin heating (hot tub "Jacuzzi" effect, perineal hot water spray). However, to date, there have been no formal studies of this non-invasive form of treatment, and the mechanism of action is still unclear.

This is a two-day study in which each subject will receive an oral fluid load and then one (1) heating treatment with the device. Ultrasound-based measurements of bladder volume will be performed both before and after voiding. On Day 1, voiding will be performed in a standing position; on Day 2, voiding will be done in a sitting position.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male subjects 25-80 years of age at the screening visit.
  • Subject must have mild-to-moderate urinary hesitancy symptoms (shown as an American Urological Association Symptom Index (AUA-SI) score of 7-19).
  • Symptoms include (not limited to):
  • Leaking or dribbling of urine
  • More frequent urination, especially at night
  • Urgency to urinate
  • Urine retention (inability to urinate)
  • Hesitant, interrupter or weak stream of urine
  • Inability or difficulty to urinate in public

排除标准

  • History of prostate cancer or prostate surgery
  • Currently (or within the past 30 days) on active treatment for prostate problems

结局指标

主要结局

Post-void residual urinary volume (PVR)

时间窗: Both Study Day 1 & 2 before/after oral fluid load

次要结局

  • Voided volume percentage (%) based on pre-void and post-void ultrasound volumes(Both Study Day 1 & 2 before/after oral fluid load)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验